|
45
|
213
|
5m32L |
Human 26s proteasome in complex with oprozomib |
|
62
|
241
|
5m2bG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
69
|
243
|
5m2bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
40
|
234
|
5m32E |
Human 26s proteasome in complex with oprozomib |
|
60
|
195
|
5m2bJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
47
|
237
|
5m32G |
Human 26s proteasome in complex with oprozomib |
|
60
|
195
|
5l6bJ |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
71
|
244
|
5l6aB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
211
|
5l6cK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
241
|
5l69G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
250
|
5l6bA |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
68
|
242
|
5l68D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
65
|
211
|
5l6aK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
195
|
5l69J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
58
|
226
|
5l6cH |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
226
|
5l5uH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
233
|
5l5rM |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
61
|
231
|
5l64E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
242
|
5l6bD |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
70
|
243
|
5l62F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
195
|
5l6cJ |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
57
|
204
|
5l5rI |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
70
|
244
|
5l6cB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
204
|
5l5sI |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
240
|
5l6cC |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
196
|
5l66N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
68
|
250
|
5l5wA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
61
|
241
|
5l60G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
233
|
5l64M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
58
|
195
|
5l63J |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
70
|
243
|
5l65F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
62
|
234
|
5lezE |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
61
|
233
|
5lezD |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
66
|
201
|
5le5K |
Native human 20s proteasome at 1.8 angstrom |
|
75
|
248
|
5lf3B |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
69
|
239
|
5lexF |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
62
|
220
|
5lezH |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
55
|
204
|
5lezI |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
67
|
216
|
5lexM |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
63
|
233
|
5lexD |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
66
|
200
|
5lf7K |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
64
|
237
|
5lexC |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
62
|
220
|
5le5H |
Native human 20s proteasome at 1.8 angstrom |
|
69
|
230
|
5le5A |
Native human 20s proteasome at 1.8 angstrom |
|
54
|
196
|
5le5J |
Native human 20s proteasome at 1.8 angstrom |
|
65
|
244
|
5lf7G |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
67
|
237
|
5lf7C |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
60
|
237
|
5lf0C |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
62
|
233
|
5lf4D |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
64
|
234
|
5le5E |
Native human 20s proteasome at 1.8 angstrom |
